A newly identified MAGE-3-derived epitope recognized by HLA-A24- restricted cytotoxic T lymphocytes

International Journal of Cancer

Volumn 81, Issue 3, 1999, Pages 387-394

  Masatake, Oiso ^a   Eura, Masao ^a   Katsura, Fumihiro ^a   Takiguchi, Masafumi ^a   Sobao, Yuji ^a   Masuyama, Keisuke ^a   Nakashima, Manabu ^b   Itoh, Kyogo ^c   Ishikawa, Takeru ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

ARTICLE; BINDING AFFINITY; CANCER GENETICS; CELL LINE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DATA ANALYSIS; HELPER CELL; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MULTIGENE FAMILY; PRIORITY JOURNAL; SUPPRESSOR CELL; TUMOR CELL CULTURE;

EID: 0032912207     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990505)81:3<387::AID-IJC12>3.0.CO;2-Z     Document Type: Article

References (22)

1. CELIS, E., TSAI, V., CRIMI, C., DEMARS, R., WENTWORTH, P.A., CHESNUT, R.W., GREY, H.M., SETTE, A. and SERRA, H.H., Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. nat. Acad. Sci. (Wash.), 91, 2105-2109 (1994).
2. DATE, Y., KIMURA, H., KATO, H. and SASAZUKI, T., DNA typing of the HLA-A gene: population study and identification of four new alleles in Japanese. Tissue Antigens, 47, 93-101 (1996).
3. DE PLAEN, E. and 14 OTHERS, Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics, 40, 360-369 (1994).
4. EURA, M., OGI, K., CHIKAMATSU, K., LEE, K.D., NAKANO, K., MASUYAMA, K., ITOH, K. and ISHIKAWA, T., Expression of the MAGE gene family in human head-and-neck squamous-cell carcinomas. Int. J. Cancer, 64, 304-308 (1995).
5. FLEISCHHAUER, K., FRUCI, D., VAN ENDERT, P., HERMAN, P., TANZARELLA, S., WALLNY, H.J., COULIE, P., BORDIGNON, C. and TRAVERSARI, C., Characterization of antigenic peptides presented by HLA-B44 molecules on tumor cells expressing the gene MAGE-3. Int. J. Cancer, 68, 622-628 (1996).
6. GAUGLER, B., VAN DEN EYNDE, B., VAN DER BRUGGEN, P., ROMERO, P., GAFORIO, J.J., DE PLAEN, E., LETHÉ, B., BRASSEUR, F. and BOON, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. exp. Med., 179, 921-930 (1994).
7. IBE, M., IKEDA-MOORE, Y., MIWA, K., KANEKO, K., YOKOTA, S. and TAKIGUCHI, M., Role of strong anchor residues in the effective binding of 10-mer and 11-mer peptides to HLA-A *2402 molecules. Immunogenetics, 44, 233-241 (1996).
8. IKEDA-MOORE, Y., TOMIYAMA, H., MIWA, K., OKA, S., IWAMOTO, A., KANEKO, Y. and TAKIGUCHI, M., Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1. J. Immunol., 159, 6242-6252 (1997).
9. IMANISHI, T. and GOJOBORI, T., Patterns of nucleotide substitutions inferred from the phytogenies of the class I major-histocompatibility-complex genes. J. mol. Evol. 35, 196-204 (1992).
10. KARAKI, S., KARIYONE, A., KATO, N., KANO, Y. IWAKURA, Y. and TAKIGUCHI, M., HLA-B51 transgenic mice as recipients for production of polymorphic HLA-A. B-specific antibodies, Immunogenetics, 37, 139-142 (1993).
11. KIKUCHI, A., SAKAGUCHI, T., MIWA, K., TAKAMIYA, Y. RAMMENSEE, H-G., KANEKO, Y. and TAKIGUCHI, M., Binding of nonamer peptides to 3 HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket. Immunogenetics, 43, 268-276 (1996).
12. KONDO, A., SIDNEY, J., SOUTHWOOD, S., DEL GUERCIO, M.F., APPELLA, E., SAKAMOTO, H., CELIS, E., GREY, H.M., CHESNUT, R.W., KUBO, R.T. and SETTE, A., Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules. J. Immunol., 155, 4307-4312 (1995).
13. KUBO, R.T. and 12 OTHERS, Definition of specific peptide motifs for four major HLA alleles. J. Immunol., 152, 3913-3924 (1994).
14. MARINCOLA, P.M., RIVOLTINI, L., SALGALLER, M.L., PLAYER, M. and ROSENBERG, S.A., Differential anti-MART-//Melan A CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthy donors: evidence of in vivo priming by tumor cells. J. Immunother., 19, 266-277 (1996).
15. OISO, M., NISHI, T., ISHIKAWA. T., NISHIMURA, Y. and MATSUSHITA, S., Differential binding of peptides substituted at putative C-terminal anchor residues to HLA-DQ8 and DQ9 differing only at B57. Hum. Immunol., 52, 47-53 (1997).
16. PATARD, J.J., BRASSEUR, F., GIL-DIEZ, S., RADVANYI, F., MARCHAND, M., FRANÇOIS, P., ABI-AAD, A., VAN CANGH, P., ABBOU, C.C., CHOPIN, D. and BOON, T., Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int. J. Cancer, 64, 60-64 (1995).
17. PERA, C., DELFINO, L., MORABITO, A., LONG, A., JOHNSTON-DOW, L., WHITE, C.B., COLONNA, M. and FERRARA, G.B., HLA-A typing: comparison between serology, the amplification refractory mutation system with polymerase chain reaction and sequencing. Tissue Antigens, 50, 372-379 (1997).
18. TANAKA, F., FUJIE, T., TAHARA, K., MORI, M., TAKESAKO, K., SETTE, A., CELIS, E. and AKIYOSHI, T., Induction of antitumor cytotoxic T lymphocytes with a MAGE-3-encoded synthetic peptide presented by human leukocytes antigen-A24. Cancer Res., 57, 4465-4468 (1997a).
19. TANAKA, F. MORI, M., Lt, J., FUJIE, T., MIMORI, K., HARAGUCHI, M., TANAKA, Y., MAFUNE, K.-I. and AKIYOSHI, T., High frequency of the expression of the MAGE gene family in human esophageal carcinoma. Int. J. Oncol., 10, 1113-1117 (1997b).
20. VAN DER BRUGGEN, P., BASTIN, J., GAJEWSKI, T., COULIE, P.G., BOEL, P., DE SMET, C. TRAVERSARI, C., TOWNSEND, A. and BOON, T., A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Europ. J. Immunol., 24, 3038-3043 (1994).
21. VAN DER BRUGGEN, P., TRAVERSARI, C., CHOMEZ, P., LURQUIN, C., DE PLAN, E., VAN DEN EYNDE, B., KNUTH, A. and BOON, T., A gene encoding an antigen recognized by cytotoxic T lymphocytes on a human melanoma. Science, 254, 1643-1647 (1991).
22. WÖLFEL, T., VAN PEL, A. and BRICHARD, V., Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Europ. J. Immunol., 24, 759-764 (1994).